Pericytes in Alzheimer's disease: Key players and therapeutic targets

被引:2
|
作者
Zhang, Yu [1 ]
Mu, Ben-Rong [1 ]
Ran, Zhao [1 ]
Zhu, Tao [1 ]
Huang, Xin [2 ]
Yang, Xiong [1 ]
Wang, Dong-Mei [3 ]
Ma, Quan-Hong [2 ,4 ]
Lu, Mei-Hong [1 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Coll Med Technol, Chongqing Key Lab Sichuan Chongqing Coconstruct Di, Chengdu 611137, Peoples R China
[2] Soochow Univ, Inst Neurosci, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Coll Basic Med Sci, Chengdu 611137, Sichuan, Peoples R China
[4] 1166 Liutai Ave, Chengdu 611137, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; Blood-brain barrier; Neurodegenerative disorder; Pericytes; Therapeutic targets; BLOOD-BRAIN-BARRIER; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; MODEL; PATHOGENESIS; ORIGIN; COMMUNICATION; VASCULATURE; DYSFUNCTION; DISRUPTION;
D O I
10.1016/j.expneurol.2024.114825
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a devastating neurodegenerative disorder that leads to progressive cognitive decline and neuropathological changes. Pericytes, which are vessel mural cells on the basement membrane of capillaries, play a crucial role in regulating cerebrovascular functions and maintaining neurovascular unit integrity. Emerging research substantiates the involvement of pericytes in AD. This review provides a comprehensive overview of pericytes, including their structure, origin, and markers and various functions within the central nervous system. Emphatically, the review explores the intricate mechanisms through which pericytes contribute to AD, including their interactions with amyloid beta and apolipoprotein E, as well as various signaling pathways. The review also highlights potential for targeted pericyte therapy for AD, with a focus on stem cell therapy and drug treatments. Future research directions include the classification of pericyte subtypes, studies related to aging, and the role of pericytes in exosome-related mechanisms in AD pathology. In conclusion, this review consolidates current knowledge on the pivotal roles of pericytes in AD and their potential as therapeutic targets, providing valuable insights for future research and clinical interventions aimed at addressing the impact of AD on patients' lives.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease
    Devi, Kasi Pandima
    Shanmuganathan, Balakrishnan
    Manayi, Azadeh
    Nabavi, Seyed Fazel
    Nabavi, Seyed Mohammad
    MOLECULAR NEUROBIOLOGY, 2017, 54 (09) : 7028 - 7041
  • [22] Rho GTPases as therapeutic targets in Alzheimer’s disease
    Byron J. Aguilar
    Yi Zhu
    Qun Lu
    Alzheimer's Research & Therapy, 9
  • [23] β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease
    Teng Jiang
    Jin-Tai Yu
    Meng-Shan Tan
    Xi-Chen Zhu
    Lan Tan
    Molecular Neurobiology, 2013, 48 : 812 - 818
  • [24] Alzheimer's disease: molecular concepts and therapeutic targets
    Fassbender, K
    Masters, C
    Beyreuther, K
    NATURWISSENSCHAFTEN, 2001, 88 (06) : 261 - 267
  • [25] Aβ OLIGOMERS AS DIAGNOSTIC AND THERAPEUTIC TARGETS FOR ALZHEIMER'S DISEASE
    Masters, Colin
    Robert, B.
    Ryan, T.
    Lind, M.
    Li, Q-X.
    Watt, A.
    Cherny, R.
    Barnham, K.
    NEUROBIOLOGY OF AGING, 2012, 33 : S21 - S22
  • [26] Presenilins as therapeutic targets for the treatment of Alzheimer's disease
    Golde, TE
    Younkin, SG
    TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) : 264 - 269
  • [27] Tau modifiers as therapeutic targets for Alzheimer's disease
    Liu, Q
    Lee, HG
    Honda, K
    Siedlak, SL
    Harris, PLR
    Cash, AD
    Zhu, XW
    Avila, JI
    Nunomura, A
    Takeda, A
    Smith, MA
    Perry, G
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2005, 1739 (2-3): : 211 - 215
  • [28] Are mitophagy enhancers therapeutic targets for Alzheimer's disease?
    Pradeepkiran, Jangampalli Adi
    Hindle, Ashly
    Kshirsagar, Sudhir
    Reddy, P. Hemachandra
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [29] Nuclear receptors as therapeutic targets for Alzheimer's disease
    Mandrekar-Colucci, Shweta
    Landreth, Gary E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (09) : 1085 - 1097
  • [30] Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
    Corbo, Christopher P.
    Alonso, Alejandra del C.
    BRAIN AS A DRUG TARGET, 2011, 98 : 47 - 83